Information for Authors

General Information
FAQs
Instructions for Authors


General Information

• Submit your manuscript
• Track the progress of your manuscript as it moves through the peer-review process
• Save on mailing charges
• Accelerate the time to acceptance

3 Steps:

1. Please read the detailed manuscript submission instructions: Information for Authors
2. Click on the required forms you'll need to download and return:

• STEM CELLS Financial Disclosure Form
• Copyright Assignment
• Submission Fee Form

3. Then go to http://mc.manuscriptcentral.com/stemcells to submit your manuscript.

Adobe Acrobat® Reader™ is required to open the Information for Authors, as well as all supporting forms. Click here to download Adobe Acrobat® Reader™.

Word limits and figure maximums for each category:
(Excluding abstracts, tables, figures, legends and references)

• Maximum 5,000 words
• Maximum of seven figures and tables
• Maximum 250 word Abstract

Specific Questions:
Click here to send email to the Editorial Office.

For technical assistance in uploading your manuscript files, there is a "Get Help Now" button in Manuscript Central.

Other documents:
Permissions Information form 

Editorial Policy

PEER-REVIEW PROCESS

STEM CELLS abides by a policy of anonymous peer review. As a single-blind review process, authors do not know the identity of their reviewers. The Editor and Associate Editors appoint Editorial Board members to lead the reviews and select external reviewers from a database of experts. These reviewers provide comments for the Editors and the authors, as well as a publication recommendation. Upon receiving the comments, the Associate Editor responsible for the manuscript makes a recommendation to the Editor, who must endorse all final manuscript decisions. Often, the Editors seek manuscript opinions from one another and/or discuss decisions.

Acceptance of manuscripts is based on originality and importance to the field, as assessed by the Editors. Acceptance and publication decisions are made by the Editors. For further information, see the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals,” published by the International Committee of Medical Journal Editors (ICMJE) .

Based on editorial judgment, some submissions are rejected initially without external review. If review is required, authors may expect to learn of rejection or acceptance in approximately 2 weeks.

Upon completion of review, the Editors’ decision will be e-mailed to the corresponding author, along with the reviewers’ comments. The author will receive one of the following decisions:

Reject: The Editors did not select your manuscript for publication. Many factors contribute to acceptance including, but not limited to, the following:
• Importance of the research to the field of translational medicine
• Originality of the work
• Quality of the study
• Priority of the work to STEM CELLS and its readership
If an author disagrees with the editorial decision, cordial inquiry is invited. The response must be timely and include a detailed rebuttal.

Major Revision: The Editors believe that your article contained information of potential importance but a number of major issues were raised. The editors would be willing to reconsider your manuscript, but cannot guarantee acceptance , particularly if you cannot address the concerns.

Minor Revision: The Editors found your manuscript potentially acceptable for publication, provided you make some minor adjustments.

Acceptance: The Editors selected your manuscript for publication. Additional information will be provided via separate email regarding embargo policies and the production process.

The Editor, Associate Editor, Concise Review Editor and Science Editors, along with the Executive and Managing Editors, make up the Senior Editorial Faculty. STEM CELLS, recognized as an icon of excellence in the field, has one of the world’s most highly respected international editorial boards with an extensive worldwide database of high profile external reviewers.
 

NIH Public Access Mandate

Wiley-Blackwell will support our authors by posting the accepted version of articles by NIH grant-holders to PubMed Central upon acceptance by the journal. The accepted version is the version that incorporates all amendments made during peer review, but prior to the publisher’s copy-editing and typesetting. This accepted version will be made publicly available 12 months after publication. The NIH mandate applies to all articles based on research that has been wholly or partially funded by the NIH and that are accepted for publication on or after April 7, 2008.

NIH authors should be aware that they will receive an e-mail request once Wiley-Blackwell has posted the files of their accepted manuscript to the NIH Manuscript Submission system to approve the upload for display on the PubMed Central system. This is a requirement of their grant/affiliation.

For NIH employees only, we will accept the NIH Publishing Agreement.

The societies for whom we publish may decide on a different policy. We will continue to brief them on any discussions that we have with the NIH regarding the processing of the articles, appropriate acknowledgements with citation and linking to the final published version on the publisher’s site, and clear licensing terms and conditions for the use of copyrighted material.

In addition, Wiley-Blackwell will continue to consult directly with authors, editors and society partners to determine how we as their publisher may best support them going forward.

Reprints and Permissions

STEM CELLS can publish borrowed material only with written permission of the original publisher. If you use illustrations and tables in your manuscript that are obtained from other sources, you must obtain permission from the original source for each. Secure these permissions as soon as possible. To assist you in this process, click here for a helpful checklist to follow for each permission required.

COPYRIGHT NOTICE

STEM CELLS® (pISSN 1066-5099) and STEM CELLS Online (eISSN-1549-4918) and all contributions included therein are protected by copyright. All rights are reserved under United States and international copyright laws and other applicable laws and conventions. No copyright is claimed in any original work created by agencies or employees of the United States government.

No part of this publication may be reproduced or transmitted in any form without the prior written consent of AlphaMed Press or Copyright Clearance Center. Certain provisions of the Copyright Act of 1976, as amended, respecting fair use and reproduction by libraries and archives, 17 U.S.C. §§ 107 and 108, may be applicable.

--------------------------------------------------------------------------------

REPRINTS

Author and Corporate Reprints are available, with covers or other customized marketing information. To order, contact Beth Ann Rocheleau, Reprint Representative, Rockwater, Inc., PO Box 2211, Lexington, SC 29071 USA. Email: brocheleau@rockwaterinc.com; Tel: +1 803-359-4578.  Please include the following information:

• Title of the Article.
• Author(s) of the Article.
• Volume and Number of STEM CELLS in which the article appeared.
• Number of reprints requested (minimum order is 100).
• Your preference of service: Economy service requires approximately 15 working days; or Priority service requires only 5 working days.

--------------------------------------------------------------------------------

PERMISSIONS

Procedure to Request Permission

Permission requests, as described below, to photocopy, distribute, and republish material from STEM CELLS should be directed to the Copyright Clearance Center (CCC):

• Classroom handouts
• Print and electronic coursepacks
• Interlibrary loan
• Library reserves
• Business purposes (sharing information with investors, prospects, clients, and partners)
• Republish figures, tables, abstracts, or excerpts in another book, journal, or newsletter
• Republish figures, tables, abstracts, or excerpts in a brochure or pamphlet
• Use of figures, tables, abstracts, or excerpts in PowerPoint
• Use of figures, tables, abstracts, or excerpts in a dissertation or thesis paper

The CCC will grant requests only to reproduce our material exactly as it was originally published. You can submit your request to the CCC via traditional mail, fax, or email. Additionally, you can secure permission online using their automated online system. Submit requests to:

Traditional mail: CCC, 222 Rosewood Drive, Danvers, Massachusetts 01923, USA
Telephone: 978-750-8400 (8:00 am-5:30 pm EST)
Fax: 978-646-8600
Email: info@copyright.com
Online: www.copyright.com

All other permission requests should be made in writing to the Permissions Department, c/o John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030: (201) 748-6011, fax (201) 748-6008, E-mail: permreq@wiley.com, and should include a statement of intended use, as well as explicit specifications of the materials to be reproduced. When submitting your permission request, please include the following information:

• A complete citation of the requested material (title of journal, volume number, issue number, year, author name, article title, specific page numbers)
• The intended use of the material (for publication, slides, handouts, etc.)
• If for handouts: the number of copies being made
• If for republication: the publisher and the name of the new publication
• How the material will be reproduced and distributed
• Complete contact details (name, institution/company name, address, telephone, fax, email)

Internet sites interested in linking to information published by John Wiley & Sons must submit a written request and include the following information: Originating website URL, company business focus, complete contact information, and description of the specific page or material to be linked.

Authors
As an author, you are granted rights for a large number of author uses, including use by your employing institute or company. These rights are granted and permitted without the need to obtain specific permission from AlphaMed Press, provided a full credit line is prominently placed (i.e., author name(s), journal name, copyright year, volume number, inclusive pages, and copyright holder). The author rights include:

• the right to make copies of the article for your own personal use, including for your own classroom teaching use;
• the right to make copies and distribute copies (including through email) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g., via an email list or list serve);
• the right to present the article at a meeting or conference and to distribute copies of such paper or article to the delegates attending the meeting;
• for the author’s employer, if the article is a “work for hire,” made within the scope of the author’s employment, the right to use all or part of the information in (any version of) the article for other intra-company use (e.g., training);
• patent and trademark rights and rights to any process or procedure described in the article;
• the right to include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
• the right to use the article or any part thereof in a printed compilation of works of the author, such as collected writings or lecture notes (subsequent to publication of the article in the journal);
• the right to prepare other derivative works, to extend the article into book-length form, or to otherwise reuse portions or excerpts in other works, with full acknowledgment of its original publication in the journal; and
• the right to post their work as the final peer-reviewed author’s manuscript (but not published layout) on their own website, their institution’s website (website only, NOT repository), and their funding body’s archive, provided a link is made to the STEM CELLS version.

Wellcome Trust-Funded Articles

Since October 1, 2006, Wellcome Trust grantees are required to submit an electronic copy of the final manuscripts of their research papers to PMC or UKPubMed Central (UKPMC). The Wellcome Trust requires that the author’s work be made available to the public via PMC and PMC mirror sites no later than six months after final publication. AlphaMed Press and Wiley-Blackwell have established a policy that will allow authors who publish in STEM CELLS to comply with these requirements.

AlphaMed Press and Wiley-Blackwell authorize Wellcome Trust-funded authors whose papers are accepted and published in STEM CELLS permission to deposit the author’s peer-reviewed manuscript (but not published format) in PMC and UKPMC no earlier than six months after the print publication in STEM CELLS. Additionally, the author is authorized to replace the peer-reviewed author manuscript with the final published version 12 months after print publication in STEM CELLS. Further information on the Wellcome Trust policy is available at: http://www.wellcome.ac.uk/node3302.html .